The Who, When, Why, and How of PET Amyloid Imaging in Management of Alzheimer’s Disease—Review of Literature and Interesting Images
Amyloid imaging using positron emission tomography (PET) has an emerging role in the management of Alzheimer’s disease (AD). The basis of this imaging is grounded on the fact that the hallmark of AD is the histological detection of beta amyloid plaques (Aβ) at post mortem autopsy....
Main Authors: | Subapriya Suppiah, Mellanie-Anne Didier, Sobhan Vinjamuri |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-06-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/9/2/65 |
Similar Items
-
Is Imaging Bacteria with PET a Realistic Option or an Illusion?
by: Shashi B. Singh, et al.
Published: (2023-03-01) -
Image Quality and Quantitative PET Parameters of Low-Dose [<sup>18</sup>F]FDG PET in a Long Axial Field-of-View PET/CT Scanner
by: Eduardo Calderón, et al.
Published: (2023-10-01) -
PET Imaging Biomarkers of Anti-EGFR Immunotherapy in Esophageal Squamous Cell Carcinoma Models
by: Tae Sup Lee, et al.
Published: (2018-10-01) -
The who, when, why, and how of PET Amyloid imaging in management of Alzheimer’s disease-review of literature and interesting images
by: Suppiah, Subapriya, et al.
Published: (2019) -
Long Axial Field-of-View PET for Ultra-Low-Dose Imaging of Non-Hodgkin Lymphoma during Pregnancy
by: Joyce van Sluis, et al.
Published: (2022-12-01)